نتایج جستجو برای: lam

تعداد نتایج: 6996  

Journal: :Thorax 2005
M M Cohen S Pollock-BarZiv S R Johnson

OBJECTIVE To provide a comprehensive update of the clinical picture of lymphangioleiomyomatosis (LAM) using two large patient registries. METHODS A cross sectional questionnaire survey which included questions on 14 LAM symptoms, pneumothorax, tuberous sclerosis complex (TSC), date of diagnosis, and pulmonary function tests (PFTs). RESULTS The response rate was 70.5% (n = 328). The mean age...

2007
Raju Venkata Veera Tatituri Luke J. Alderwick Arun K. Mishra Jerome Nigou Martine Gilleron Karin Krumbach Paul Hitchen Assunta Giordano Howard R. Morris Anne Dell Lothar Eggeling Gurdyal S. Besra

Arabinan polysaccharide side-chains are present in both Mycobacterium tuberculosis and Corynebacterium glutamicum in the heteropolysaccharide arabinogalactan (AG), and in M. tuberculosis in the lipoglycan lipoarabinomannan (LAM). This study shows by quantitative sugar and glycosyl linkage analysis that C. glutamicum possesses a much smaller LAM version, Cg-LAM, characterized by single t-Araf re...

2016
Hong Joo Kim Soo Kyung Park Hyo Joon Yang Yoon Suk Jung Jung Ho Park Dong Il Park Yong Kyun Cho Chong Il Sohn Woo Kyu Jeon Byung Ik Kim Kyu Yong Choi

BACKGROUND/AIMS To analyze the effects of preexisting lamivudine (LAM) resistance and applying antiviral treatment (adefovir [ADV] add-on LAM combination treatment) on long-term treatment outcomes, and comparing the clinical outcomes of antiviral-naïve chronic hepatitis B patients receiving entecavir (ETV) monotherapy. METHODS This study enrolled 73 antiviral-naïve patients who received 0.5-m...

2015
Bidisha Paul Chowdhury Syamdas Bandyopadhyay Shibali Das Saikat Majumder Mukesh Kumar Jha Suchandra Bhattacharyya Majumdar Bhaskar Saha Subrata Majumdar

Visceral leishmaniasis (VL), which is endemic as a major infectious disease in the tropical and subtropical countries, is caused by a protozoan parasite Leishmania donovani. At present, restricted treatment options and lack of vaccines intensify the problem of controlling VL. Therefore, finding a novel immunoprophylactic or therapeutic principle is a pressing need. Here, we report that arabinos...

2014
Hua Zhang Calvin Q Pan Qiumei Pang Ruihua Tian Miaoe Yan Xin Liu

UNLABELLED Little observational data exist describing telbivudine (LdT) or lamivudine (LAM) use in late pregnancy for preventing hepatitis B mother-to-child transmission (MTCT) in real-world settings. During the period of January 2009 to March 2011, we enrolled hepatitis B e antigen-positive mothers with HBV DNA >6 log10 copies/mL in China. At gestation week 28, the mothers received LdT or LAM ...

Journal: :Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2015
M Y Chung O Y K Wan R Y K Cheung T K H Chung S S C Chan

OBJECTIVES Levator ani muscle (LAM) injury is common after first vaginal delivery, and a higher incidence is associated with instrumental delivery. This study was conducted to compare the incidence of LAM injury after forceps or ventouse extraction in primiparous Chinese women, and to study their subsequent health-related quality of life. METHODS This prospective observational study was condu...

2009
Angelo M Taveira-DaSilva Wendy K Steagall Joel Moss

Lymphangioleiomyomatosis (LAM), a multisystem disease affecting predominantly premenopausal and middle-aged women, causes progressive respiratory failure due to cystic lung destruction and is associated with lymphatic and kidney tumors. In the past, the treatment of LAM comprised exclusively anti-estrogen and related hormonal therapies. These treatments, however, have not been proven effective....

2018
Ajay Kumar Verma Ambarish Joshi Amritesh Ranjan Mishra Surya Kant Arpita Singh

Spontaneous pneumothorax is a very common medical emergency. Patients are often treated without treating the underlying cause. Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease. Until recently, diagnosis of LAM was a challenge with nearly 100% mortality in 10 years, but better understanding of the disease through research and better radiological techniques and newer drugs such as sir...

Journal: :The European respiratory journal 2010
S R Johnson J F Cordier R Lazor V Cottin U Costabel S Harari M Reynaud-Gaubert A Boehler M Brauner H Popper F Bonetti C Kingswood

Patients with LAM usually develop progressive dyspnoea and recurrent pneumothorax, chylous collections and occasional haemoptysis [1]. Extra pulmonary lymphadenopathy and cystic masses of the axial lymphatics termed lymphangioleiomyomas can result in abdominal and pelvic lymphatic obstruction [7]. LAM is often associated with angiomyolipoma in the kidneys [8], and an increased frequency of meni...

2012
Deokkyu Kim Sung Nyu Lee Sang-Kyi Lee Jeongwoo Lee

Lymphangiomyomatosis (LAM) is a rare lung disease that is characterized by the progressive proliferation of atypical smooth muscle-like cells, which leads to severe respiratory impairment and death. Dyspnea, cough, recurrent pneumothorax, and hemoptysis are the most common clinical symptoms of LAM. We report a 29-year-old female patient with massive hemoptysis during laparoscopic gynecologic su...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید